Ask AI

Research Focus in Advanced NSCLC: Emerging Insights on Next-Generation KRAS G12C Inhibitors

Enhance your knowledge of next-generation KRAS G12C–targeted therapies for NSCLC for optimal integration into clinical practice through a certified text module with accompanying downloadable slides, expert-authored ClinicalThought commentary, and podcast.

Share

Program Content

Activities

KRAS G12C Therapies in NSCLC
Advancing KRAS G12C-Targeted Therapies in NSCLC: Current Evidence and Future Directions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 10, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from Genentech, a member of the Roche Group and Lilly.

Genentech, a member of the Roche Group

Lilly